榴莲视频

Absolute risk remains low, however

Trials now enroll lower-risk women who get better treatment, analysis suggests

Adding inavolisib to palbociclib/fulvestrant more than doubled PFS in endocrine-resistant disease

Bladder, brain, and cervical cancer risks were higher in people with MS

Health news and commentary gathered by 榴莲视频 staff

Higher risk for ever use, increasing duration of use but no increase in BRCA2 carriers

Health news and commentary gathered by 榴莲视频 staff

Trial finds similar complication and recurrence rates with hypofractionated versus standard RT

Numerical advantage in randomized trial, non-randomized study misses noninferiority mark

Study suggests differences in how the ACA cost-sharing exemption is applied across patient groups

Actual rates for 2021 lagged behind projections

Other studies look at financial toxicity for teen/young adult cancer patients, nausea after chemo

Also in TTHealthWatch: youth and opioids, and pembrolizumab for triple-negative breast cancer

"Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says